PT - JOURNAL ARTICLE AU - Mozaffer, Farhina AU - Cherian, Philip AU - Krishna, Sandeep AU - Wahl, Brian AU - Menon, Gautam I TI - Effect of hybrid immunity, school reopening, and the Omicron variant on trajectory of COVID-19 epidemic in India: A modelling study AID - 10.1101/2022.06.24.22276854 DP - 2022 Jan 01 TA - medRxiv PG - 2022.06.24.22276854 4099 - http://medrxiv.org/content/early/2022/06/26/2022.06.24.22276854.short 4100 - http://medrxiv.org/content/early/2022/06/26/2022.06.24.22276854.full AB - Background The course of the COVID-19 pandemic has been driven by several dynamic behavioral, immunological, and viral factors. We used mathematical modeling to explore how the concurrent reopening of schools, increasing levels of hybrid immunity, and the emergence of the Omicron variant have affected the trajectory of the pandemic in India, using the model Indian state of Andhra Pradesh (pop: 53 million).Methods We constructed an age- and contact-structured compartmental model that allows for individuals to proceed through various states depending on whether they have received zero, one, or two doses of the COVID-19 vaccine. Our model is calibrated using results from other models as well as available serosurvey data. The introduction of the Omicron variant is modelled alongside protection gained from hybrid immunity. We predict disease dynamics in the background of hybrid immunity coming from infections and well as an ongoing vaccination program, given prior levels of seropositivity from earlier waves of infection. We describe the consequences of school reopening on cases across different age-bands, as well as the impact of the Omicron (BA.2) variant.Results We show the existence of an epidemic peak that is strongly related to the value of background seroprevalence. As expected, because children were not vaccinated in India, re-opening schools increases the number of cases in children more than in adults, although most such cases are asymptomatic or mild. The height of this peak reduced as the background infection-induced seropositivity was increased from 20% to 40%. At reported values of seropositivity of 64%, no discernable peak was seen. We also explore counterfactual scenarios regarding the effect of vaccination on hybrid immunity. We find that in the absence of vaccination, even at such high levels of seroprevalence, the emergence of the Omicron variant would have resulted in a large rise in cases across all age bands. We conclude that the presence of high levels of hybrid immunity thus resulted in relatively fewer cases in the Omicron wave than in the Delta wave.Interpretation In India, the decreasing prevalence of immunologically naïve individuals of all ages helped reduce the number of cases reported once schools were reopened. In addition, hybrid immunity, together with the lower intrinsic severity of disease associated with the Omicron variant, contributed to low reported COVID-19 hospitalizations and deaths.Funding World Health Organization, MphasisCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the World Health Organization and Mphasis.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAggregated case and vaccination data are available www.covid19india.org and www.covid19bharat.org. https://www.covid19bharat.org https://www.covid19india.org